A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Conditions
Autoimmune Hepatitis · Primary Sclerosing Cholangitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Stanford University, Palo Alto, California, United States
Contact: Principal Investigator (Leina Alrabadi, MD)Jennifer Halma, MD (Sub-investigator)Riley Children's Health, Indianapolis, Indiana, United States
Contact: Principal Investigator (Kyla Tolliver, MD)St. Louis Children's Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (Sakil S Kulkarni, MD)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Amy E Taylor, MD)Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Aishwarya R. Keesara, BDS, MS) · Aishwarya.keesara@nationwidechildrens.org · 234-973-2602Contact: Study coordinator (Suneetha Atluri, MBBS) · Suneetha.atluri@nationwidechildrens.org · 260-450-1487Contact: Principal Investigator (Alexander Weymann, MD)UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Laura Mathews, Research Coordinator, BS) · mathewslj3@upmc.edu · 412-692-5811Contact: Principal Investigator (James E Squires, MD)Mary H Ayers, MD (Sub-investigator)UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Sindhu Pandurangi, MD)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Chelsea S Caranto, BS) · chelsea.caranto@seattlechildrens.org · 206-987-4636Contact: Principal Investigator (Katelyn M Saarela, DO)
Study leads
Amy E Taylor, MD
Principal Investigator
Children's Hospital Medical Center, Cincinnati